-The Telegraph Ranchi: The state information commission, mandated to ensure enactment of a sunshine law that aims to empower citizens by allowing access to crucial official documents and decisions has stopped work in Jharkhand as it has no officer to hear cases. Headed by chief information commissioner Justice (retired) D.K.Sinha, the commission is meant to have 10 information commissioners (IC) to hear cases filed under the Right to Information Act. But, all posts...
More »SEARCH RESULT
Total Matching Records found : 1087
At MNCs, sexual harassment complainants face uphill battle-Vinaya Deshpande
-The Hindu Though Bill on protection of women against sexual harassment at workplace has been passed in LS, activists are sceptical about its impact on MNCs They are powerful Multi-National Corporations (MNCs) which hold a clout in the market, but have flouted norms with impunity when it came to their own women staffers complaining of sexual harassment at workplace. Now, even as the country is set to welcome the first law for...
More »UIDAI mum on Aadhaar cards for Prime Minister, Sonia
-The Times of India HYDERABAD: A recent RTI query to the Unique Identification Authority of India (UIDAI) for information on whether India's 'top brass' possessed Aadhaar cards, has come back without any response. The RTI query was filed by city activist Rakesh Reddy. While Reddy, under the Act, demanded to know if Prime Minister Manmohan Singh, UPA chairperson Sonia Gandhi, UIDAI chairman Nandan Nilekani, deputy chairman of Planning Commission Montek Singh Ahluwalia...
More »Natco Pharma wins cancer drug case-R Sivaraman
-The Hindu Bayer's plea dismissed by the Intellectual Property Appellate Board The Intellectual Property Appellate Board (IPAB) on Monday upheld the grant of compulsory licence (CL) to the Hyderabad-based Natco Pharma Limited, a generic drug maker, to produce and market Nexavar, a patented cancer drug of multinational pharma major Bayer Corporation. The order will pave the way for reduction in the prices of costly life saving drugs. Disposing an appeal filed by Bayer...
More »Bayer plea dismissed, Natco allowed to sell patent cancer drug
-The Business Standard Chennai: The Intellectual Property Appellate Board (IPAB) today upheld a compulsory licence issued by the Controller of Patents to Hyderabad-based Natco Pharma Ltd, a generic drug maker, to manufacture and sell a cancer drug of Bayer Corp in India. IPAB, however, made changes in the licence order by increasing the royalty payment to Bayer Corp for Nexavar, used to treat liver and kidney cancer, from six per cent to...
More »
